Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3 (2013), 1–150.
Bengahnem Gharbi, M., Elseviers, M., et al. Chronic kidney disease, hypertension, diabetes, and obesity in the adult population of Morocco: how to avoid “over” and “under” diagnosis of CKD. Kidney Int 89 (2016), 1363–1371.
Brück, K., Stel, V.S., Gambaro, G., et al. CKD prevalence varies across the European general population. J Am Soc Nephrol 27 (2015), 2135–2147.
Delanaye, P., Too much nephrology? The CKD epidemic is real and concerning. A CON view. Nephrol Dial Transplant 34 (2019), 581–584.
Jonsson, A.J., Lund, S.H., Eriksen, B.O., et al. The prevalence of chronic kidney disease in Iceland according to KDIGO criteria and age-adapted estimated glomerular filtration rate thresholds. Kidney Int 98 (2020), 1286–1295.
Eriksen, B.O., Ingebretsen, O.C., The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int 69 (2006), 375–382.
de Jong, P.E., Gansevoort, R.T., Fact or fiction of the epidemic of chronic kidney disease—let us not squabble about estimated GFR only, but also focus on albuminuria. Nephrol Dial Transplant 23 (2008), 1092–1095.
Delanaye, P., Jager, K.J., Bolkenkamp, A., et al. CKD: a call for an age-adapted definition. J Am Soc Nephrol 30 (2019), 1785–1805.
GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395(10225):709–733.
